{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:16:32Z","timestamp":1788304592985,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_20","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:46:40Z","timestamp":1788302800000},"page":"323-342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Examination of Class I HLA-Fc Fusion Proteins in Targeting Cognate Antibody-Producing Cells"],"prefix":"10.1007","author":[{"given":"Ashlee M.","family":"Webber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Edelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","volume":"337","author":"Trial to Reduce Alloimmunization to Platelets Study Group","year":"1997","unstructured":"Trial to Reduce Alloimmunization to Platelets Study Group (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 337:1861\u20131869","journal-title":"N Engl J Med"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJM196904032801401","volume":"280","author":"R Patel","year":"1969","unstructured":"Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735\u2013739","journal-title":"N Engl J Med"},{"key":"20_CR3","doi-asserted-by":"crossref","unstructured":"Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL (2011) Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 365:318\u2013326","DOI":"10.1056\/NEJMoa1012376"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.humimm.2017.09.004","volume":"78","author":"SP Persaud","year":"2017","unstructured":"Persaud SP, Duffy B, Phelan DL, Mohanakumar T, Delos Santos R, Gaut JP, Liu C (2017) Accelerated humoral renal allograft rejection due to HLA-C14 mediated allosensitization to HLA-Bw6. Hum Immunol 78:692\u2013698","journal-title":"Hum Immunol"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1182\/blood-2009-09-244525","volume":"115","author":"S Spellman","year":"2010","unstructured":"Spellman S, Bray R, Rosen-Bronson S, Haagenson M, Klein J, Flesch S, Vierra-Green C, Anasetti C (2010) The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 115:2704\u20132708","journal-title":"Blood"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1182\/blood-2011-06-362111","volume":"118","author":"SO Ciurea","year":"2011","unstructured":"Ciurea SO, Thall PF, Wang X, Wang SA, Hu Y, Cano P, Aung F, Rondon G, Molldrem JJ, Korbling M, Shpall EJ, de Lima M, Champlin RE, Fernandez-Vina M (2011) Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood 118:5957\u20135964","journal-title":"Blood"},{"key":"20_CR7","unstructured":"National data - OPTN. https:\/\/optn.transplant.hrsa.gov\/data\/view-data-reports\/national-data\/. Accessed 12 Feb 2022"},{"key":"20_CR8","doi-asserted-by":"crossref","unstructured":"Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB (2009) The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 49:1825\u20131835","DOI":"10.1111\/j.1537-2995.2009.02206.x"},{"key":"20_CR9","doi-asserted-by":"crossref","unstructured":"Pottebaum AA, Venkatachalam K, Liu C, Brennan DC, Murad H, Malone AF, Alhamad T (2020) Efficacy and safety of tocilizumab in the treatment of acute active antibody-mediated rejection in kidney transplant recipients. Transplant Direct 6:e543","DOI":"10.1097\/TXD.0000000000000988"},{"key":"20_CR10","doi-asserted-by":"publisher","unstructured":"Pottebaum AA, January SE, Liu C, Lavine S, Schilling JD, Lavine KJ (2023) Feasibility of interleukin-6 receptor blockade in cardiac antibody-mediated rejection. Transplantation. https:\/\/doi.org\/10.1097\/TP.0000000000004784","DOI":"10.1097\/TP.0000000000004784"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1111\/ajt.13341","volume":"15","author":"C Wiebe","year":"2015","unstructured":"Wiebe C, Nevins TE, Robiner WN, Thomas W, Matas AJ, Nickerson PW (2015) The synergistic effect of class II HLA epitope\u2010mismatch and nonadherence on acute rejection and graft survival. Am J Transplant 15:2197\u20132202","journal-title":"Am J Transplant"},{"key":"20_CR12","doi-asserted-by":"crossref","unstructured":"Velidedeoglu E, Cavaill\u00e9-Coll MW, Bala S, Belen OA, Wang Y, Albrecht R (2018) Summary of 2017 FDA public workshop: antibody-mediated rejection in kidney transplantation. Transplantation 102:e257\u2013e264","DOI":"10.1097\/TP.0000000000002141"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/trf.12923","volume":"55","author":"C Yamada","year":"2015","unstructured":"Yamada C, Ramon DS, Cascalho M, Sung RS, Leichtman AB, Samaniego M, Davenport RD (2015) Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Transfusion 55:727\u2013735","journal-title":"Transfusion"},{"key":"20_CR14","doi-asserted-by":"crossref","unstructured":"Macklin PS, Morris PJ, Knight SR (2017) A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection. Transplant Rev 31:87\u201395","DOI":"10.1016\/j.trre.2017.01.002"},{"key":"20_CR15","doi-asserted-by":"crossref","unstructured":"Woodle ES, Tremblay S, Rossi A, Rojas CC, Alloway R, Roskin K, Allman D, Hildeman D (2020) Plasma cell targeting to prevent antibody-mediated rejection. Am J Transplant 20 Suppl 4:33\u201341","DOI":"10.1111\/ajt.15889"},{"key":"20_CR16","doi-asserted-by":"crossref","unstructured":"Walsh RC, Brailey P, Girnita A, Alloway RR, Shields AR, Wall GE, Sadaka BH, Cardi M, Tevar A, Govil A, Mogilishetty G, Roy-Chaudhury P, Woodle ES (2011) Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition. Transplantation 91:1218\u20131226","DOI":"10.1097\/TP.0b013e318218e901"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1111\/ajt.15364","volume":"19","author":"WH Marks","year":"2019","unstructured":"Marks WH, Mamode N, Montgomery RA, Stegall MD, Ratner LE, Cornell LD, Rowshani AT, Colvin RB, Dain B, Boice JA, Glotz D, C10-001 Study Group (2019) Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: a randomized trial. Am J Transplant 19:2876\u20132888","journal-title":"Am J Transplant"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.healun.2023.05.012","volume":"42","author":"SE January","year":"2023","unstructured":"January SE, Fester KA, Halverson LP, Witt CA, Byers DE, Vazquez-Guillamet R, Alexander-Brett J, Tague LK, Kreisel D, Gelman A, Puri V, Bahena RN, Takahashi T, Hachem RR, Kulkarni HS (2023) Tocilizumab for antibody-mediated rejection treatment in lung transplantation. J Heart Lung Transplant 42:1353\u20131357","journal-title":"J Heart Lung Transplant"},{"key":"20_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14853","volume":"37","author":"P Khairallah","year":"2022","unstructured":"Khairallah P, Robbins-Juarez S, Patel S, Shah V, Toma K, Fernandez H, Dube GK, King K, Mohan S, Husain SA, Morris H, Crew RJ (2022) Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients. Clin Transplant 37:e14853","journal-title":"Clin Transplant"},{"key":"20_CR20","doi-asserted-by":"publisher","unstructured":"Kjellman C, Maldonado AQ, Sj\u00f6holm K, Lonze BE, Montgomery RA, Runstr\u00f6m A, Lorant T, Desai NM, Legendre C, Lundgren T, von Zur M\u00fchlen B, Vo AA, Olsson H, Jordan SC (2021) Outcomes at 3 years post-transplant in imlifidase-desensitized kidney transplant patients. Am J Transplant. https:\/\/doi.org\/10.1111\/ajt.16754","DOI":"10.1111\/ajt.16754"},{"key":"20_CR21","doi-asserted-by":"crossref","unstructured":"Webber AM, Bradstreet TR, Wang X, Guo H, Nelson CA, Fremont DH, Edelson BT, Liu C (2022) Antigen-guided depletion of anti-HLA antibody-producing cells by HLA-Fc fusion proteins. Blood 140:1803\u20131815","DOI":"10.1182\/blood.2022016376"},{"key":"20_CR22","doi-asserted-by":"crossref","unstructured":"Hansen TH, Connolly JM, Gould KG, Fremont DH (2010) Basic and translational applications of engineered MHC class I proteins. Trends Immunol 31:363\u2013369","DOI":"10.1016\/j.it.2010.07.003"},{"key":"20_CR23","doi-asserted-by":"crossref","unstructured":"Hansen T, Yu YYL, Fremont DH (2009) Preparation of stable single-chain trimers engineered with peptide, beta2 microglobulin, and MHC heavy chain. Curr Protoc Immunol Chapter 17:Unit17.5","DOI":"10.1002\/0471142735.im1705s87"},{"key":"20_CR24","doi-asserted-by":"crossref","unstructured":"Truscott SM, Wang X, Lybarger L, Biddison WE, McBerry C, Martinko JM, Connolly JM, Linette GP, Fremont DH, Hansen TH, Carreno BM (2008) Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides. J Biol Chem 283:7480\u20137490","DOI":"10.1074\/jbc.M709935200"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","volume":"292","author":"M Lo","year":"2017","unstructured":"Lo M, Kim HS, Tong RK, Bainbridge TW, Vernes J-M, Zhang Y, Lin YL, Chung S, Dennis MS, Zuchero YJY, Watts RJ, Couch JA, Meng YG, Atwal JK, Brezski RJ, Spiess C, Ernst JA (2017) Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice. J Biol Chem 292:3900\u20133908","journal-title":"J Biol Chem"},{"key":"20_CR26","doi-asserted-by":"crossref","unstructured":"Petersen TN, Brunak S, von Heijne G, Nielsen H (2011) SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 8:785\u2013786","DOI":"10.1038\/nmeth.1701"},{"key":"20_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000709","volume":"3","author":"C Liu","year":"2017","unstructured":"Liu C, Pang S, Phelan D, Brennan DC, Mohanakumar T (2017) Quantitative evaluation of the impact of ethylenediaminetetraacetic acid pretreatment on single-antigen bead assay. Transplant Direct 3:e194","journal-title":"Transplant Direct"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1093\/ajcp\/aqad150.259","volume":"160","author":"R Frick","year":"2023","unstructured":"Frick R, Wetter L, Phelan D, Liu C, Tang MS (2023) Evaluation of different microbead volumes in a single antigen bead assay for HLA antibody detection. Am J Clin Pathol 160:S118\u2013S119","journal-title":"Am J Clin Pathol"},{"key":"20_CR29","doi-asserted-by":"crossref","unstructured":"Reed EF, Rao P, Zhang Z, Gebel H, Bray RA, Guleria I, Lunz J, Mohanakumar T, Nickerson P, Tambur AR, Zeevi A, Heeger PS, Gjertson D (2013) Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant 13:1859\u20131870","DOI":"10.1111\/ajt.12287"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:46:42Z","timestamp":1788302802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"11 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}